Infliximab for the treatment of fistulas in patients with Crohn's disease. - sprookjes - yvandenbroek - TriplyDB

Infliximab for the treatment of fistulas in patients with Crohn's disease.

Infliximab for the treatment of fistulas in patients with Crohn's disease.

http://www.wikidata.org/entity/Q33860666

about

Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study European evidence based consensus on the diagnosis and management of Crohn's disease: special situations Adverse effects of biologics: a network meta-analysis and Cochrane overview Thalidomide and thalidomide analogues for induction of remission in Crohn's disease Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease Medical immunology: a new journal for a new subspecialty.Immunotherapy of systemic sclerosis What every gastroenterologist needs to know about common anorectal disorders Reoperative Crohn's surgery: tricks of the trade Postoperative enterocutaneous fistula: when to reoperate and how to succeed Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis Inflammatory bowel disease surgery in the biologic era Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?Ustekinumab for the treatment of Crohn's disease: can it find its niche?Economic implications of biological therapy for Crohn's disease How should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease?Indications and Specific Surgical Techniques in Crohn's Disease Medical Therapy of Perianal Crohn's Disease Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments Inflammatory pathways of importance for management of inflammatory bowel disease Vedolizumab for inflammatory bowel disease: Changing the game, or more of the same?Use of the tumor necrosis factor-blockers for Crohn's disease Anti-TNF-alpha therapy and systemic vasculitis.Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease Pharmacogenetics in inflammatory bowel disease How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?Review article: Infliximab therapy for inflammatory bowel disease--seven years on The JNK inhibitor XG-102 protects against TNBS-induced colitis.Perianal Crohn's disease.Management of complex perianal Crohn's disease Evolving Concepts in Phases I and II Drug Development for Crohn's Disease.Treatment of perianal fistula in Crohn's disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment.Infliximab.CDP571, a humanised monoclonal antibody to tumour necrosis factor alpha, for moderate to severe Crohn's disease: a randomised, double blind, placebo controlled trial.Medical management of Crohn's disease: current therapy and recent advances.The impact of JNK inhibitor D-JNKI-1 in a murine model of chronic colitis induced by dextran sulfate sodium.

P2860

Q22000875-BF45947B-5109-4B0B-85D6-AAB07E552EF7 Q22242050-10C403C0-0315-4E46-A978-28DB15170407 Q24234197-D4496B95-9EF7-4860-9E2B-89159654B735 Q24241766-95440FAD-D7ED-4446-BED5-4CD18A444FA2 Q24242101-82D675DC-17A3-472D-854E-DCF7560C10EB Q24247745-9A576A3E-D99B-4A09-8B23-F69BB74C2EAC Q24538980-D94A4829-2627-4F12-95FC-2499392C9B1F Q24634395-731C634E-D727-4211-8BBC-573B95D47D34 Q24648664-2544DE2B-B9D1-4280-82C7-3D17DFB6F99D Q24653602-EFC57352-70E1-4FBC-AC5C-166495A6B1D1 Q24653675-12E1472B-6C57-4BF7-B253-6028129CFCB2 Q24669692-9E34DA1B-C2AC-409D-827B-3294B18B1C24 Q24669999-3CA0F64B-E4B0-40C8-9D49-B5E25370A044 Q24798468-F22019B4-4C71-4969-9E09-326B84111287 Q24803670-090D81A7-2837-4687-93BE-A71BBF6007A9 Q26745627-018E9DDA-F0AF-4E49-9D2C-DCD8F84009E1 Q26765352-ACCB6233-3024-4183-99B0-1C3B4E5C2A61 Q26771890-1B101C7A-E893-48A2-A219-5CEDD8FE35FA Q26772179-773D9239-8C88-43DD-990F-BBE9A22765F6 Q26777409-EE8B3EC4-4B88-420A-BEE2-0A9DA73F0E68 Q26777720-956E876A-A02C-4E3A-B23C-533156571A8C Q26777722-2965DA54-D4C3-49DA-86D4-AAA59499CD37 Q26785537-FE30B867-933B-4381-B991-C06B5E35A79A Q27005445-1AD00C9E-B565-4B31-AF31-A28E5C32F610 Q27021612-1A4D9C19-9AC4-4785-BD91-8B94C1E031B6 Q27030762-105A9F81-84EC-4EF1-913C-644B982EFC52 Q27687590-F3B0484E-D750-462A-817C-4D6556D1352C Q28188982-8EDBD779-5229-485D-B62B-EED885E42B49 Q28246002-F1B09A94-5B38-49F4-9722-E060EB323EE7 Q28251305-190264C7-AF33-40CF-AE8D-C874F3BAEC67 Q28294134-32E6CACC-4FC4-45EC-9395-BA507B8FA7BF Q28481470-54B34DCF-EF43-40B7-9F62-47F2FCDF0082 Q29346975-6881656F-7606-436D-8D99-9ECFFF5796E7 Q30239850-C95141FD-4075-4237-A133-FFEEC2E735F1 Q30248641-697B4D54-E9C0-4C81-BB75-573F879684BA Q30251864-2999E311-1065-43F7-9B2C-D87C2E055486 Q30307998-41413957-6BEA-42CD-A426-2BEBC73147A4 Q30444398-A563B401-2FAD-4DAE-BA7D-B3FF0C819DEF Q30450875-3E910CB8-1FC6-4739-A11F-8263893DDC38 Q30454726-A46EFCE9-3008-42B2-947B-DCF461C58075

P2860

Infliximab for the treatment of fistulas in patients with Crohn's disease.

http://www.wikidata.org/entity/Q33860666

description

1999 nî lūn-bûn

@nan

1999 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Infliximab for the treatment of fistulas in patients with Crohn's disease.

@ast

Infliximab for the treatment of fistulas in patients with Crohn's disease.

@en

type

label

Infliximab for the treatment of fistulas in patients with Crohn's disease.

@ast

Infliximab for the treatment of fistulas in patients with Crohn's disease.

@en

prefLabel

Infliximab for the treatment of fistulas in patients with Crohn's disease.

@ast

Infliximab for the treatment of fistulas in patients with Crohn's disease.

@en

P1433

Q33860666-CC7CD1BD-C56C-472B-AF48-7A0990AEFC02

P1476

Q33860666-B9393091-5AD8-435B-A1D9-B16B0C0BDE32

P2093

Q33860666-0AC7218C-705A-418B-B20B-0BBE2EF89BF9

Q33860666-156AC7FA-2B25-4DD7-9E1E-06291AD2045E

Q33860666-20AED730-759A-4A92-9E12-0126543C2641

Q33860666-50DC8081-1A39-4CFB-A845-2D1CD292170A

Q33860666-A4829D04-3BE0-45CA-97E9-A5BB0DCFA710

Q33860666-A5158A25-F070-4A13-B97B-92D58E36C8E6

Q33860666-BD17D415-B88F-4FA9-B9F8-6B173A8D0F6F

Q33860666-C2C477F4-F86F-4A9E-95DB-182F448B0EE4

Q33860666-C3AB50B8-4249-4AC6-9291-DC4C12EE4B47

Q33860666-CD38C153-CD2B-4D85-AB7F-A9962B8EFC44

P304

Q33860666-013C81A1-05CD-4F82-9ABD-14ADC3D3F726

P31

Q33860666-BD438A76-205C-4440-AD2C-815E1D6EEB06

P356

Q33860666-9C76B8B5-8AEE-479D-87A3-0ABCA38C573D

P407

Q33860666-25576334-0869-4A3D-A604-6A0DABAFAA1E

P433

Q33860666-CDD0AA68-0EDE-446F-A52A-41991798E420

P478

Q33860666-0FFCF53D-E4BC-467B-A3C5-17B867C334A8

P577

Q33860666-70757C0D-2537-44D8-8E60-6F72C345E1F2

P698

Q33860666-72B4633A-BB00-4704-B3B1-D39341429DB2

P921

Q33860666-19D44D7A-8BF5-4EAF-92D2-747273104D0B

Q33860666-241F570B-1712-4823-8826-F381695DDB24

P356

NEJM199905063401804

P1433

The New England Journal of Medicine

P1476

Infliximab for the treatment of fistulas in patients with Crohn's disease.

@en

P2093

Braakman T

http://www.w3.org/2001/XMLSchema#string

DeWoody KL

http://www.w3.org/2001/XMLSchema#string

Hanauer SB

http://www.w3.org/2001/XMLSchema#string

Mayer L

http://www.w3.org/2001/XMLSchema#string

Podolsky DK

http://www.w3.org/2001/XMLSchema#string

Present DH

http://www.w3.org/2001/XMLSchema#string

Rutgeerts P

http://www.w3.org/2001/XMLSchema#string

Sands BE

http://www.w3.org/2001/XMLSchema#string

Schaible TF

http://www.w3.org/2001/XMLSchema#string

Targan S

http://www.w3.org/2001/XMLSchema#string

P304

1398-1405

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJM199905063401804

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

340

http://www.w3.org/2001/XMLSchema#string

P577

1999-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10228190

http://www.w3.org/2001/XMLSchema#string

P921

Crohn's disease